Cardiovascular

Cardiovascular·MeSH: Dyslipidemias

Prevalence

8121.9 / 100K

Incidence

682.0 / 100K/yr

106 drugs in development·60 companies·3 clinical trials

Drug Pipeline by Phase

Approved(44)

Drug	Company
amlodipine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
AMVUTTRA	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
assure wearable cardioverter defibrillator system	Kestra Medical Technologies Ltd. (KMTS)
candesartan cilexetil	Aptinyx Inc. (APTX)
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
exforge hct	Novartis AG (NVS)
felodipine	Mylan II B.V. (MYL)
huoliyuan	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
inoue-balloon catheter	AMERICA GREAT HEALTH (CWNM)
Jardiance	ELI LILLY & Co (LLY)
Jardiance®	ELI LILLY & Co (LLY)
lastac system	Vincerx Pharma, Inc. (VINC)
lifespan 100 tcpco2 monitor	International Stem Cell CORP (ISCO)
losartan	Mylan II B.V. (MYL)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
meta dddr pacing system	RHYTHM PHARMACEUTICALS, INC. (RYTM)
model 515 neonatal moniotr	GE HealthCare Technologies Inc. (GEHC)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
omnicarbon cardiac valve prosthesis	CV Sciences, Inc. (CVSI)
ozempic	Novo Nordisk A/S (NVO)
prasugrel	Mylan II B.V. (MYL)
pravastatin	Aptinyx Inc. (APTX)
siberian ginseng series	Fuss Brands Corp. (FBDS)
spironolactone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
surestat arterial closure system	Q BioMed Inc. (QBIO)
tapscope 550	Cardio Diagnostics Holdings Inc. (CDIO)
technetium tc 99m sestamibi	Cardinal Health Inc. (CAH)
telmisartan	Inventiva S.A. (IVA)
ticagrelor	Amneal Pharmaceuticals, Inc. (AMRX)
ticagrelor	Mylan II B.V. (MYL)
ticagrelor	DR REDDYS LABORATORIES LTD (RDY)
tirofiban	NEXUS BIOPHARMA INC (NEXS)
Trulicity	ELI LILLY & Co (LLY)
Trulicity®	ELI LILLY & Co (LLY)
valsartan	Mylan II B.V. (MYL)
vascepa	AMARIN CORP PLCUK (AMRN)
vascepa	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA in EU)	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA)	AMARIN CORP PLCUK (AMRN)
vazalore	PLX PHARMA INC. (DPRX)
Verquvo	Merck & Co., Inc. (MRK)
versatrax pacing system	RHYTHM PHARMACEUTICALS, INC. (RYTM)
wrapsody cell-impermeable endoprosthesis	Merit Medical Systems Inc. (MMSI)

Phase 3(20)

Drug	Company
[14c]azd0780	ASTRAZENECA PLC (AZN)
[14c]azd0780 solution for infusion	ASTRAZENECA PLC (AZN)
akcea-apo-lrx	AKCEA THERAPEUTICS, INC. (AKCA)
AZD0780	ASTRAZENECA PLC (AZN)
azd1705	ASTRAZENECA PLC (AZN)
BE1116	Valneva SE (VALN)
BE1116	ENANTA PHARMACEUTICALS INC (ENTA)
FFP	ENANTA PHARMACEUTICALS INC (ENTA)
FFP	Valneva SE (VALN)
inclisiran sodium 300 mg in	Novartis AG (NVS)
inclisiran sodium 300 mg in	Novartis AG (NVS)
lepodisiran	ELI LILLY & Co (LLY)
Lepodisiran Sodium	ELI LILLY & Co (LLY)
Olpasiran	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
pelacarsen	Novartis AG (NVS)
Standard Medical Therapy	Merus N.V. (MRUS)
tqj230	Novartis AG (NVS)
tqj230	Novartis AG (NVS)
Zerlasiran	Silence Therapeutics Plc (SLN)
Zilebesiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Phase 2(8)

Drug	Company
akcea-angptl3-lrx	AKCEA THERAPEUTICS, INC. (AKCA)
cibotercept (KER-012)	Keros Therapeutics, Inc. (KROS)
evolocumab	Novo Nordisk A/S (NVO)
nnc0385-0434 a	Novo Nordisk A/S (NVO)
olinciguat	Cyclerion Therapeutics, Inc. (CYCN)
olpasiran	AMGEN INC (AMGN)
sln360	Silence Therapeutics Plc (SLN)
vtx3232	Ventyx Biosciences, Inc. (VTYX)

Phase 1(5)

Drug	Company
BGE-102	BioAge Labs, Inc. (BIOA)
CTX310	CRISPR Therapeutics AG (CRSP)
CTX320	CRISPR Therapeutics AG (CRSP)
ziltivekimab b	Novo Nordisk A/S (NVO)
ziltivekimab c	Novo Nordisk A/S (NVO)

Preclinical(5)

Drug	Company
anti-il-1a antibody	XBiotech Inc. (XBIT)
cdx-101	CARDAX, INC. (CDXI)
electroceuticals therapeutic devices	ENDONOVO THERAPEUTICS, INC. (ENDV)
non-complement cardiovascular target candidate	RA PHARMACEUTICALS, INC. (RARX)
testing services for clinical trials	INTERLEUKIN GENETICS INC (ILIU)

Unknown(20)

Drug	Company
alirocumab	Sanofi (SNYNF)
alirocumab	Sanofi (SNY)
amplia mri crt-d	RHYTHM PHARMACEUTICALS, INC. (RYTM)
biofreedom drug coated coronary stent system	International Stem Cell CORP (ISCO)
capsure	RHYTHM PHARMACEUTICALS, INC. (RYTM)
capsure sp	RHYTHM PHARMACEUTICALS, INC. (RYTM)
coseal surgical sealant; coseal spray set	Bio Green Med Solution, Inc. (BGMSP)
HeartRisk™	Cardio Diagnostics Holdings Inc. (CDIO)
icast covered stent system	Avidity Biosciences, Inc. (RNAM)
inclisiran	Sanofi (SNY)
inclisiran	Sanofi (SNYNF)
magellan-c percutaneous transluminal coronary angioplasty catheters model c22020	Global Blood Therapeutics, Inc. (GBT)
magellan-c percutaneous transluminal coronary angioplasty catheters model c22020	GLOBAL FUTURE CITY HOLDING INC. (FTCY)
marquis/maximo/intrinsic icds	RHYTHM PHARMACEUTICALS, INC. (RYTM)
on-x prosthetic heart valve	XBiotech Inc. (XBIT)
repel-cv bioresorbable adhesion barrier	Cryo-Cell International Inc. (CCEL)
rithron-xr coronary stent system	Co-Diagnostics Inc. (CODX)
scoreflex nc scoring ptca catheter	Co-Diagnostics Inc. (CODX)
simpson-robert family of coronary dilatation catheters	Advanced Biomed Inc. (ADVB)
stellarex 0.035 drug coated balloon percutaneous transluminal angioplasty catheter	The Beauty Health Company (SKIN)

Phase 1/Phase 2(2)

Drug	Company
CTX321	CRISPR Therapeutics AG (CRSP)
tb-500	IO Biotech, Inc. (IOBT)

Phase 4(2)

Drug	Company
Atozet 10/40 mg or 10/80 mg	Organon & Co. (OGN)
Liposomal bupivacaine	Cidara Therapeutics, Inc. (CDTX)

Compare drugs

amlodipine vs AMVUTTRA amlodipine vs assure wearable cardioverter defibrillator system amlodipine vs candesartan cilexetil

Frequently asked questions

How many drugs are in development for Cardiovascular?

BioSniper tracks 106 drugs in development for Cardiovascular across 60 companies.

How many clinical trials target Cardiovascular?

There are 3 clinical trials targeting Cardiovascular tracked by BioSniper.

What is the prevalence of Cardiovascular?

The estimated prevalence of Cardiovascular is approximately 8121.9 per 100,000 population.

Deep-dive into Cardiovascular

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis